Kazia Therapeutics (KZIA) Invested Capital (2009 - 2025)

Kazia Therapeutics (KZIA) has 14 years of Invested Capital data on file, last reported at $9.3 million in Q4 2025.

• In Q4 2025, Invested Capital rose 605.56% year-over-year to $9.3 million; the TTM figure through Dec 2025 stood at $11.4 million (changed N/A YoY), while the FY2025 annual figure was $2.8 million, down 11.86% from the prior year.
• Invested Capital rose to $9.3 million in Q4 2025, from $2.8 million in the prior quarter.
• Across five years, Invested Capital topped out at $29.1 million in Q2 2021 and bottomed at $1.3 million in Q4 2024.
• A 5-year average of $9.8 million and a median of $9.0 million in 2023 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2024 — Invested Capital sank 85.38% — and 2025, when it soared 605.56%.
• Year by year, Invested Capital stood at $29.1 million in 2021, then sank by 73.89% to $7.6 million in 2022, then grew by 18.62% to $9.0 million in 2023, then sank by 85.38% to $1.3 million in 2024, then soared by 605.56% to $9.3 million in 2025.
• The last three Invested Capital figures came in at $9.3 million (Q4 2025), $2.8 million (Q2 2025), and $1.3 million (Q4 2024), per Business Quant data.

Peer Comparison